"SEER Program" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)
Descriptor ID |
D018426
|
MeSH Number(s) |
E05.318.308.970.725 N04.452.859.819.725 N05.715.360.300.715.700.725 N06.850.520.308.970.725
|
Concept/Terms |
SEER Program- SEER Program
- Program, SEER
- SEER Program (National Cancer Institute (U.S.))
- Surveillance, Epidemiology, and End Results Program
|
Below are MeSH descriptors whose meaning is more general than "SEER Program".
Below are MeSH descriptors whose meaning is more specific than "SEER Program".
This graph shows the total number of publications written about "SEER Program" by people in this website by year, and whether "SEER Program" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 1 | 1 |
2006 | 1 | 2 | 3 |
2009 | 0 | 1 | 1 |
2010 | 2 | 0 | 2 |
2011 | 0 | 3 | 3 |
2012 | 0 | 1 | 1 |
2013 | 0 | 3 | 3 |
2014 | 0 | 4 | 4 |
2015 | 0 | 2 | 2 |
2016 | 0 | 6 | 6 |
2017 | 0 | 2 | 2 |
2018 | 1 | 3 | 4 |
2019 | 1 | 1 | 2 |
2020 | 0 | 2 | 2 |
2021 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "SEER Program" by people in Profiles.
-
Kidney Cancer Incidence among Non-Hispanic American Indian and Alaska Native Populations in the United States, 1999 to 2020. Cancer Epidemiol Biomarkers Prev. 2024 Aug 01; 33(8):1065-1072.
-
Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2023 05; 23(5):379-384.
-
Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype. J Clin Oncol. 2023 02 10; 41(5):1059-1068.
-
Long-term outcomes of primary cardiac malignant tumors: Difference between African American and Caucasian population. Cancer Med. 2021 12; 10(24):8838-8845.
-
Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study. World Neurosurg. 2022 01; 157:e245-e253.
-
Health care-related time costs in patients with metastatic breast cancer. Cancer Med. 2020 11; 9(22):8423-8431.
-
Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016. Clin Breast Cancer. 2020 08; 20(4):e410-e422.
-
Carcinoma ex pleomorphic adenoma: A review of incidence, demographics, risk factors, and survival. Am J Otolaryngol. 2019 Nov - Dec; 40(6):102279.
-
Salivary Carcinosarcoma: An Extremely Rare and Highly Aggressive Malignancy. Laryngoscope. 2020 05; 130(5):E335-E339.
-
Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer. Ann Surg Oncol. 2018 Dec; 25(13):4027-4034.